rs149024147

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4BS1BS2

This summary comes from the ClinGen Evidence Repository: The NM_005629.4:c.544G>A variant in SLC6A8 is a missense variant predicted to cause substitution of valine by methionine at amino acid 182 (p.Val182Met). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00084 (16/19086 alleles) in the African/African American population, meeting the CCDS VCEP’s allele frequency threshold for BS1 (>0.0002) (BS1). This variant is present in 5 or more hemizygotes in gnomAD v2.1.1 (BS2). Furthermore, the variant did not segregate with intellectual disability in multiple brothers, and the proband with the variant had normal urine creatine and normal cerebral creatine on 1H-magnetic resonance spectroscopy (PMID 16738945). The computational predictor REVEL gives a score of 0.184, evidence that does not predict a damaging effect on SLC6A8 function, and SpliceAI predicts no impact of the variant on splicing (BP4). There is a ClinVar entry for this variant (Variation ID: 465147). In summary, this variant meets the criteria to be classified as benign for creatine transporter deficiency. SLC6A8-specific ACMG/AMP codes met, as specified by the ClinGen CCDS VCEP (Specifications Version 1.1.0): BS1, BS2, BP4.(Classification approved by the ClinGen CCDS VCEP on June 6, 2022). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10549204/MONDO:0010305/027

Frequency

Genomes: 𝑓 0.00030 ( 1 hom., 13 hem., cov: 25)
Exomes 𝑓: 0.000031 ( 0 hom. 12 hem. )

Consequence

SLC6A8
NM_005629.4 missense

Scores

1
3
13

Clinical Significance

Benign reviewed by expert panel U:1B:5

Conservation

PhyloP100: 1.43
Variant links:
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
BS1
BS2

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SLC6A8NM_005629.4 linkuse as main transcriptc.544G>A p.Val182Met missense_variant 3/13 ENST00000253122.10
SLC6A8NM_001142805.2 linkuse as main transcriptc.544G>A p.Val182Met missense_variant 3/13
SLC6A8NM_001142806.1 linkuse as main transcriptc.199G>A p.Val67Met missense_variant 3/13

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SLC6A8ENST00000253122.10 linkuse as main transcriptc.544G>A p.Val182Met missense_variant 3/131 NM_005629.4 P1P48029-1

Frequencies

GnomAD3 genomes
AF:
0.000300
AC:
34
AN:
113232
Hom.:
1
Cov.:
25
AF XY:
0.000367
AC XY:
13
AN XY:
35388
show subpopulations
Gnomad AFR
AF:
0.000928
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000938
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000546
AC:
10
AN:
183125
Hom.:
0
AF XY:
0.0000590
AC XY:
4
AN XY:
67785
show subpopulations
Gnomad AFR exome
AF:
0.000608
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000722
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000310
AC:
34
AN:
1097592
Hom.:
0
Cov.:
31
AF XY:
0.0000330
AC XY:
12
AN XY:
363182
show subpopulations
Gnomad4 AFR exome
AF:
0.000758
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000331
Gnomad4 SAS exome
AF:
0.0000185
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000950
Gnomad4 OTH exome
AF:
0.0000868
GnomAD4 genome
AF:
0.000300
AC:
34
AN:
113232
Hom.:
1
Cov.:
25
AF XY:
0.000367
AC XY:
13
AN XY:
35388
show subpopulations
Gnomad4 AFR
AF:
0.000928
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000938
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000246
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000494
AC:
6

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:5
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Likely benign, criteria provided, single submitterclinical testingGeneDxJun 30, 2020This variant is associated with the following publications: (PMID: 16738945) -
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsApr 24, 2018- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Creatine transporter deficiency Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeJan 29, 2024- -
Benign, reviewed by expert panelcurationClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel, ClinGenJun 06, 2022The NM_005629.4:c.544G>A variant in SLC6A8 is a missense variant predicted to cause substitution of valine by methionine at amino acid 182 (p.Val182Met). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00084 (16/19086 alleles) in the African/African American population, meeting the CCDS VCEP’s allele frequency threshold for BS1 (>0.0002) (BS1). This variant is present in 5 or more hemizygotes in gnomAD v2.1.1 (BS2). Furthermore, the variant did not segregate with intellectual disability in multiple brothers, and the proband with the variant had normal urine creatine and normal cerebral creatine on 1H-magnetic resonance spectroscopy (PMID 16738945). The computational predictor REVEL gives a score of 0.184, evidence that does not predict a damaging effect on SLC6A8 function, and SpliceAI predicts no impact of the variant on splicing (BP4). There is a ClinVar entry for this variant (Variation ID: 465147). In summary, this variant meets the criteria to be classified as benign for creatine transporter deficiency. SLC6A8-specific ACMG/AMP codes met, as specified by the ClinGen CCDS VCEP (Specifications Version 1.1.0): BS1, BS2, BP4. (Classification approved by the ClinGen CCDS VCEP on June 6, 2022). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
T;.
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.72
T;T
M_CAP
Pathogenic
0.37
D
MetaRNN
Benign
0.13
T;T
MetaSVM
Benign
-0.65
T
MutationAssessor
Benign
1.4
L;.
MutationTaster
Benign
0.60
N;N
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-0.95
N;N
REVEL
Benign
0.18
Sift
Benign
0.19
T;T
Sift4G
Benign
0.14
T;T
Polyphen
0.13
B;.
Vest4
0.22
MVP
0.69
MPC
1.3
ClinPred
0.020
T
GERP RS
3.1
Varity_R
0.24
gMVP
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149024147; hg19: chrX-152956908; API